Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00958932 · ClinicalTrials.gov registry record · NA

Telecommunication Enhanced Asthma Management

A NA study of Asthma, sponsored by National Jewish Health.

Completed
Registry status
NA
Development phase
1,187
Enrollment target
1
Study location

NCT00958932 is a NA study of Asthma that has completed, run by National Jewish Health. The registered enrollment target is 1,187 participants, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00958932, a NA study of Asthma, has completed, sponsored by National Jewish Health.

COMPLETED
Registry status
NA
Development phase
1,187 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this project is to conduct a randomized practical clinical trial within a large health maintenance organization to test a telephone intervention designed to improve adherence to daily asthma medications and thereby improve asthma outcomes. The investigators hypothesize that adherence with inhaled corticosteroid medications in the TEAM intervention group will be greater than in the usual care group.

Conditions Studied

Interventions

  • BEHAVIORAL Speech recognition

Study Locations (1)

Colorado

  • National Jewish Health - Denver

Trial Details

FieldValue
Enrollment Target 1,187 participants
Start Date 2009-09
Est. Completion 2013-05
Phase NA

Sponsor

National Jewish Health

83 total trials

What the Registry Record Tells You About NCT00958932

The ClinicalTrials.gov registry entry for NCT00958932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,187 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (24% lower). The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Speech recognition is the first listed.

NCT00958932 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT00958932 about?

NCT00958932 is a clinical study titled "Telecommunication Enhanced Asthma Management". The primary aim of this project is to conduct a randomized practical clinical trial within a large health maintenance organization to test a telephone intervention designed to improve adherence to daily asthma medications and thereby improve asthma outcomes. The investigators hypothesize that adhere...

What is the current status of trial NCT00958932?

This trial is currently completed. It is a NA study. The enrollment target is 1,187 participants. The study started on 2009-09. Estimated completion is 2013-05.

What conditions does trial NCT00958932 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00958932?

The interventions under investigation include: Speech recognition (BEHAVIORAL).

Who is sponsoring clinical trial NCT00958932?

This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00958932 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.